Neurologic disease activity in people with multiple sclerosis treated with immune checkpoint inhibitors. Conway SE, Pua DKA, Holroyd KB, Galetta K, et al. Mult Scler 2022 Aug 11:13524585221117949. doi: 10.1177/13524585221117949.

Read + Share

Amedeo Smart

Independent Medical Education

Conway SE, Pua DKA, Holroyd KB, Galetta K, et al. Neurologic disease activity in people with multiple sclerosis treated with immune checkpoint inhibitors. Mult Scler 2022 Aug 11:13524585221117949. doi: 10.1177/13524585221117949.
PMID: 35957594